Exam 1 Flashcards

(103 cards)

1
Q

Biotechnology

A

-Broadly defined
-Beginning often associated with the development of practical recombinant DNA technology

*Any technology application that uses biological systems, dead organisms, or derivatives thereof, to make or modify products or processes for specific use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Rapid progress in biotechnology

A

Made possible by
-Rapid and inexpensive automated DNA synthesis and sequencing
-Isolation of restriction enzymes to precisely excise DNA fragments
-Discovery of the polymerase chain reaction as a means of amplifying specific pieces of DNA
-Development of host organisms/cell lines for the efficient expression and purification of heterologous proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Biotechnology and the number of disciplines it interfaces with

A

-Biochemistry
-Molecular biology
-Genetics
-Organic chemistry
-Computer science
-Immunology
-Engineering
-Microbiology
-Protein chemistry
-Cell biology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Applications of biotechnology

A

-Health care
-Agriculture
-Non-food applications (biofuels/plastics, industrial catalysts, biological weapons)
-Environmental

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Advantages of using recombinant DNA technology for drug development

A
  1. Source availability
  2. Safety (Less transmission of infected diseases, isolation from dangerous or inappropriate sources)
  3. Engineering (Enables for drug like and functional prop)
  4. Economical (cheaper than biological drugs)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Scale of biopharmaceuticals vs small-molecule drugs

A

Increased complexity is a challenge in terms of production, delivery, development cost

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Diagnostics

A

Crucial component to esnure proper drug is matched to the right patient –> precision medicine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Next generation sequencing of DNA

A

Current approach to precision medicine
-easily/rapidly sequence entire human genomes
-determine which genes are active under a given disease state
-identify rare variants in cancer
-many more applications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Drug development and overview

A

Basic research
Target ID
Target validation Screening
Optimization
Pre-clinical
Phase I-IV
Indication discovery

Challenges:
-Takes a long time for this process to occur and can cost billions of dollars which is why securing the patent is important
-The science is very complex
-The market can be very competitive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Drug development for biological drugs

A

Market exclusivity is compressed for biological drugs
-Due to their being more of challenge to sequence biologics
-Biosimilar defined by its activity not by the composition
-Biologic approvals have been increasing overtime

Challenges:
-Biosimilars hard to make and most companies fund their research through production of generics
-Currently about to produce the first round of lucrative biopharmaceutical drugs –> golden age of biosimilars

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Summary of biotechnology

A

-Role in therapeutics has been long, difficult and expensive it is now producing a significant number of new approved drugs of increasing complexivity
-Driver of increased drug pricing and the complexivity of biologics is preventing competitors from entering the US market
-Drug companies are using legal defense (patent moats) to slow the entry of biosimilars

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

DNA

A

Molecule that contains the biological instructions to make each species unique
-DNA tightly packaged into a chromosome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Genome

A

An organisms complete set of nuclear and mitochondrial DNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Genes

A

Instructions to make proteins and functional RNAs
*A chromosome can contain multiple genes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

mRNA

A

DNA is transcribed into RNAs which are translated into proteins

*Encode 20 different kinds of Amino Acids present in proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Gene variants

A

-Permanent change in the DNA sequence of a gene
Do NOT always cause disease - Disease variants are uncommon
-Variations can affect one or more nucleotides in a gene
-Important variations can occur outside of genes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Gene Variant Type: Substitutions

A

Replace one nucleotide with another
-Three kinds:
-Silent changes DNA and mRNA but not protein
-Missense changes the protein
-Nonsense inserts a STOP codon which terminates translation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Gene Variant Type: Insertion

A

Adds one or more nucleotides to the gene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Gene Variant Type: Deletion

A

Deletes one or more nucleotides from the gene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Gene Variant Type: Frame shifts

A

When the gene shifts out of its normal three nucleotide sequence
*Can result from insertion and deletions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Gene Variant Type: Indel

A

When insertions and deletions occur at the same time; must be larger than a single substitution

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Gene Variant Type: Duplication

A

When a stretch of nucleotides is copied and repeated next to the original sequence; duplications often take the form of repeat expansions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Large scale DNA changes

A

Copy number variations
-Caused by large scale insertions, deletions, or duplications
-Can affect gene regulation
-Account for a significant amount of variation between individuals
-Can affect risk of disease or response to drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Copy number variation

A

When genomes contain fewer or many more than two genes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Aneuploidy
A change in chromosomes from 46 *Most individuals have 46 chromosomes *Most result in pregnancy loss EX: Trisomy 21, Monosomy X or Turner Syndrome
26
Translocation
When part of a chromosome breaks off and attaches to another chromosome *Genetic material can be gained or lost *Deletions and duplications can also occur at the chromosome level
27
Hereditary variants
Variants passed from parent to child *Present in nearly every cell in the body *Also called germline variants
28
Non-inherited variants
Variants that occur during a person's lifetime *Not present in every cell *Also called somatic variants *Cannot be passed on *Often due to environmental effect (UV radiation)
29
Mosaicism
Cells with varying genetic makeup in the body - Occurs sometime after fertilization - Could be germline or somatic depending on when/where
30
Autosomal dominant
One altered copy can cause a disorder Can be inherited or arise from a new variant EX: Huntington disease
31
Autosomal recessive
Need two altered copies for disease to be caused - Individuals with one altered copy can be carriers or have few symptoms - Typically not seen in every generation EX: Cystic fibrosis, sickle cell anemia
32
X-Linked Dominant
caused by a gene variation on the X chromosome -Females show less effect -Fathers cannot pass X linked traits to son -Those who inherit will show the disorder
33
X-linked recessive
For females: need variants on both X chromosomes For males: only need one variant (so seen more in males) *Father cannot pass X-linked traits to sons
34
Y-Linked
Disease associated variant on the Y chromosome -Variants are passed from father to son
35
Codominant
Two altered variants of the same gene (alleles) are expressed and make different proteins -Both variant influence the trait EX: ABO blood group
36
Mitochondrial
-Gene variant in the mitochondrial DNA - Inherited from the mother
37
Monogenic diseases
Genetic diseases associated with one gene, or one position on the chromosome (locus) -Tend to run in families and are inherited -Simple and better understood than polygenic diseases
38
Phenotype
The observable characteristic of a gene variant
39
Polygenic diseases
Genetic diseases that are impacted by multiple loci (positions on the chromosome)
40
Huntington Disease
Progressive brain disorder that causes uncontrolled movements, emotional problems, and loss of thinking ability --> fatal -Typically onset in adulthood -Autosomal dominant -Caused by variants in HTT gene -Contains repeats of the nucleoside triplet "CAG" -Higher numbers of CAG repeats = more severe disease progression, gain of function phenotypes
41
Gain of function (Huntington)
Excessive CAG repeats CREATE a protein with an additional, TOXIC function
42
Loss of function (Huntington)
Excessive CAG repeats REDUCE protein function
43
Sickle cell disease
-Monogenic -Affects hemoglobin -Alters shape of red blood cells--> distorted RBCs get stuck in blood vessels causing severe pain and anemia -Autosomal RECESSIVE -Caused by variants in the HBB gene -People that are heterozygous are protected from Malaria, frequency of HbS variant is highest where malaria is endemic
44
Cystic Fibrosis
-Monogenic disease -Build up of thick mucus causes respiratory/digestive problems and leads to bacterial infection -Symptoms often appear in childhood -Variants of the CFTR gene -Autosomal recessive
45
HTT gene
Role in protecting neurons from apoptosis (cell death) -Variant of this gene causes neuronal degradation
46
CFTR gene
Variant in the CFTR gene (F508del) deletes three nucleotides but the gene is left in the frame -Protein created is left unstable and is degraded by the proteasome
47
Duchenne Muscular Dystrophy (DMD)
Characterized by progressive muscle weakness and atrophy -L.E is 22 years -Variants in the DMD gene cause absence of dystrophin protein -Protein is required for muscle tissue protection during contraction -X linked recessive --> Mother passes it on, if she is a carrier male child has 50% of getting it and female child has 50% of being carrier
48
mRNA and Intros/exons
Exons code for proteins -Introns are removed by splicing
49
Alternative splicing
Results in different protein products from the same gene -Variants can affect splicing
50
Proteins relation to splicing
Exons and introns have sequences that can recruit proteins which either enhance or inhibit splicing EX: ESE, ISE = Exon/Intron splicing enhancer ESS, ISS = Exon/Intron splicing silencer
51
Antisense oligonucleotides (ASOs)
Can restore proper pre-mRNA splicing -They basically block unwanted splice sites which allow for the mutation to be stopped
52
ASOs role in DMD
Basically we can introduce a ASO which allows for an alternative splice site to be selected which allows for a shorter but functional dystrophin protein EX: Eteplirsen targets exon 51 which blocks it and allows for alternative splice site (gives shorter but functional protein)
53
Cystic Fibrosis therapy
Need multiple therapies -Elexacaftor and Tezacaftor stabilize F508del-CFTR and send it to Golgi to be sent out -Ivacaftor potentiates F508del-CFTR activity
54
How does recessive phenotype impact therapy
Just need therapy to produce a healthy protein
55
Polygenic diseases
Conditions/diseases that are caused by variants in multiple genes Modulated by lifestyle and environmental factors -Exercise -Diet -Pollution exposure -Etc. Sometimes called complex or multifactorial disorders EX: Hypertension, heart disease, type 2 diabetes, cancer
56
Polygenic diseases and family
-Found in families but inheritance is not as clear -Similarity in family lifestlyes/environment a confounding variable -Difficult to study/treat
57
Polygenic diseases and variant number
-The number of gene variants contributing to disease is generally not known -The number of variants carried by parents that can increase risk is not known -The precise qualitative impact of environmental risks is unknown
58
Genetic predisposition for polygenic diseases
-Increased likelihood of developing a disease based on the genotype -Often inherited -Can contribute to developing a disease without having it -Having a variant is not deterministic for a disease phenotype -Variants can have small or large effects -Gene variants can interact and change the disease phenotype (modifier genes) -Risk can be estimated but not strictly calculated -Family history can be used
59
Penetrance
% of individuals with a given phenotype that express it
60
Expressivity
Degree to which an individual with a given genotype expresses a phenotype
61
Example of polygenic disease: Breast Cancer
Variants in BRCA1 and BRCA 2 (DNA repair proteins) -Failure to repair DNA results in mutations that lead to cancer -Inherited variants lead to somatic variants which lead to cancer
62
Polygenic diseases: Hypertension
-High blood pressure -Uncontrolled high blood pressure can lead to cardiovascular diseases and complications
63
Genetics of Hypertension
Primary - No identifiable cause of high blood pressure - Tends to develop gradually over many years - Polygenic Secondary - Caused by an underlying disease - Tends to appear suddenly - Typically causes higher blood pressure than primary - Caused by various conditions also (genetic and environmental factors) factors) - Monogenic
64
How can we quantify risk of hypertension
1. Identify genomic variants by comparing the genomes of individuals with and without hypertension 2. Calculate which variants tend to be found more frequently in groups of people with hypertension 3. Use statistics to estimate how the collection of a person's variants affect their risk for hypertension 4. Yields polygenic risk scores 5. All of this can be done without knowing how specific genes influence hypertension
65
Bottom line about interpreting if a polygenic disease will occur
We need a lot of information to determine if SNP will result in negative health conseqeunces
66
How are genetic loci associated with diseases
Monogenic diseases -Large effect gene variants -Clearly traced through family pedigrees -The Huntington associated variant was identified by cutting human DNA with a sequence-specific enzyme -The enzyme cut the DNA is a distinct pattern
67
Genome wide association studies
Motivation: -Compared dizygotic (fraternal) and monozygotic (identical) twins revealed their was a genetic component to heritability of traits -Complex/polygenic diseases could be inherited Goal = associated genes with traits -Individual genes likely only have small effects -Scan for markers across entire genomes -Current approach to understanding polygenic diseases They catalog SNPs and examine them to determine if they more frequently in people with the disease -SNPs aren't necessarily causative of disease
68
Simple vs Complex disease
Simple/monogenic: -Severe phenotype -Early onset -Rare -Mendelian inheritance -Cystic fibrosis, osteogenesis imperfecta, etc. -Caue mutations Complex: -Mild phenotype -Late onset -Common -Complex inheritance -Diabetes, asthma, osteoporosis, etc. -Polymorphisms
69
Chips vs NGS
Chips have SNPs that people already know about, and they are very inexpensive to find out if a person has a SNP associated to disease NGS contains SNPs that are unknown
70
Genome association studies selection
Need to select: -Appropriate population -Genotyping method -Statistical analysis approach
71
Genome association study sample size
-Population and sample size -Larger populations enable identification of additional significant loci -Ancestry (if people have similar ancestry or not) -Need diverse ancestry
72
Genome association studies: Obtaining SNP info
-Hybridization arrays/chips (becoming outmoded) -Whole exome sequencing (selective sequencing of exons)
73
Whole exome sequencing
Enrich only exons for sequencing Enrichment occurs by base pairing of exons with DNA probes Pitfall? -Misses promoter sequence
74
Genome wide association studies: statistical analysis
Significant loci often contain multiple genes How many genes depends on the resolution of the SNP detection technique If we identify multiple genes within the Loci we don't know which gene causes the disease
75
Polygennic Risk scores
-Attempt to determine the relative risk for complex diseases -Considers potentially hundreds of genetic variants that modulate disease risk -Incorporates information from GWAS studies -Can assess risk for individuals or populations -Can identify cohorts for further analysis of gene disease connections -Can include environmental risk or utilize biomarkers
76
Benefits and issues with Polygenic risk scores
Benefits: -Appropriate assessment of risk could improve preemptive care Cons: -Need to consider diverse ancestries -Other issues: access, insuracne coverage, data sharing
77
Non-coding disease variants
The non-coding genome can alter the amount of RNA or protein produced by a gene (gene expression) ~90% of disease associated SNPs are found in non-coding DNA -Many of these SNPs overlap enhancers and silencers, suggesting alterations in gene expression -Effects on expression haven't been verified and it's expensive to do so
78
Elements that modify gene
-Promoters initiate gene expression and are acted on by -Enhancers increase expression -Silencers reduce expression -Insulators block the effect of enhancers at adjacent genes
79
Epigenetics
Modification of DNA that affects gene expression -Impacted by environment *DNA modification plays a potential role in disease phenotypes
80
Personalized genetics
-One size fits all approach doesn't work for everyone -Using genomics to define or predict disease -Based on individual's DNA sequence Personalized genomics = Precision genomics
81
Precision medicine
-Ideally allows for more accurate treatment and prevention strategies -Emerging field -Use of polygenic risk scores to improve patient outcomes is an example of precision medicine -mRNA vaccines can be reprogrammed to target tumors from specific patients -Engineered mRNAs express neoantigens
82
Pharmacogenomics
How a person's genetic background affects drug response is a subfield of precision medicine
83
Uses of precision medicines
Make a diagnosis Plan treatment Determine treatment efficacy Make a prognosis
84
Precision medicine cancer treatment example
Biomarkers are DNA/RNA/protein features that correlate with cancer risk or therapy efficicacy -Knowledge of biomarkers has advanced to the point where they can be used to specify treatment -Target tumors based on two markers: Short DNA repeats and DNA mismatch repair deficiency
85
Neoantigens
New proteins found on the outside of tumor cells due to DNA mutations
86
Goals of Pharmacogenomics
Avoid adverse reactions -Drug hypersensitivity Decide dosage -Slow drug metabolism --> buildup and toxicity -Fast drug metabolism ---> Lack of drug effect Overall patient health improvement
87
Pharmacogenes
Genes with varaints that affect drug pharmacokinetics or pharmacodynamics Pharmacokinetic genes -Normal metabolizers -Poor metabolizers -Intermediate metabolizers -Ultrarapid Metabolizers Pharmacodynamic genes -Positive for high risk alleles -Negative for high risk alleles Large effect -Monogenic -rare -individuals Small effect -Polygenic -Common -Populations
88
Pharmacogenomics effect on drug receptors
Varying numbers of drug receptors on cells can produce varying responses
89
Pharmacogenomics effect on drug uptake
Drug entry into target cells can be impacted by genotype
90
Pharmacogenomics effect on drug breakdown
Genotype impacts the rate of drug breakdown, which affects dosing
91
Structural variants
Large scale deletions or duplications affect drug metabolism
92
Null Allele
Has no activity or less drug metabolism
93
recombinant DNA
Any DNA molecule formed by joining DNA segments from different sources -DNA digestion/ligation -Gel electrophoresis -Hybridization -PCR -Transformation of host cells
94
Recombinant DNA basics
Restriction endonucleases cleave DNA at specific internal sequences (digestion) Cutting and pasting DNA: Restriction Enzymes and DNA ligase --> Two DNA pieces with the same unique restriction site on each end can be digested with restriction enzyme then mized and treated with DNA ligase to give joined fragments
95
Agarose
-Large DNA fragments -Moderate resolution -Horizontal gel -Standard visualization -Pulsed field --> extremely large fragments
96
PAGE
-Small DNA fragments -High resolution (single nucleotide) -Vertical gel -Standard visualization -SDS-PAGE
97
DNA Annealing
DNA double helices are denatured to single strands by heat or high pH and then slowly cooled/lower ph so that the DNA double helices are reformed via renaturation Contributing factors: -Strand length (longer = more stable) -pH, salt, temp -sequence -can be DNA/DNA, DNA/RNA, RNA, RNA -Tm = temp at 50% -USe of fluorescent dsDNA binding molecule can "report" proportion of dsDNA
98
DNA Annealing specificity
Can be modulated With appropriate stringency and sensitivity, annealing techniques can detect complementrary sequences present at the concentration of one molecule per cell
99
PCR --> Polymerase Chain Reaction
Allows amplification of any gene via base pairing specificity
100
Operons
Way of ogranizing genes Contain the following elements: 1. Regulatory gene --> codes for a protein that binds DNA and influences transcription of the structural gene(s) 2. Operator --> DNA sequence that binds the regulatory protein 3. Promoter --> DNA sequence that binds RNA polymerase in absence of repressor 4. Structural gene --> codes for nonregulatory protein(s) that have activity in metabolism
101
The lac Operon in E. Coli
Encodes three structural genes and one regulatory gene This operon is a group of genes whose expression is coregulated in response to the presence or absence of lactase as a carbon source The first important enzyme required for using lactose is B-galactosidase which cleaves lactose into galactose and glucose In operons the RBS and start codons are usually much closer to stop codon of the upstream gene
102
Cloning genes for expression
1. Plasmid is cut with 2 different restriction enzymes 2. Gene is amplified by PCR from genomic DNA 3. Primers contain same restriction sites as used to cut plasmid 4. Gene is cut to give sticky ends that are complementary to plasmid 5. Cut gene is ligated to plasmid by DNA ligase 6. Plasmid with cloned gene is added to E. Coli in presence of antibiotic Forms Expression Plasmid
103
Origin of Replication
Dictates number of plasmid copies per cell